Dashboard
Manage Tickers

VCNX VACCINEX, INC.

OTC vaccinex.com


$ -0.05 (-9.37 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 0.4751
-- x --
-- x --
-- - --
$ 0.25 - $ 1.41
61
na
3.67M
$ 2.39
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-15-2025 12-31-2024 10-K
2 11-14-2024 09-30-2024 10-Q
3 08-14-2024 06-30-2024 10-Q
4 05-15-2024 03-31-2024 10-Q
5 04-02-2024 12-31-2023 10-K
6 11-13-2023 09-30-2023 10-Q
7 08-14-2023 06-30-2023 10-Q
8 05-15-2023 03-31-2023 10-Q
9 03-31-2023 12-31-2022 10-K
10 11-14-2022 09-30-2022 10-Q
11 08-15-2022 06-30-2022 10-Q
12 05-16-2022 03-31-2022 10-Q
13 03-31-2022 12-31-2021 10-K
14 11-08-2021 09-30-2021 10-Q
15 08-16-2021 06-30-2021 10-Q
16 05-17-2021 03-31-2021 10-Q
17 03-31-2021 12-31-2020 10-K
18 11-13-2020 09-30-2020 10-Q
19 08-14-2020 06-30-2020 10-Q
20 05-14-2020 03-31-2020 10-Q
21 03-09-2020 12-31-2019 10-K
22 11-12-2019 09-30-2019 10-Q
23 08-14-2019 06-30-2019 10-Q
24 05-15-2019 03-31-2019 10-Q
25 03-13-2019 12-31-2018 10-K
26 11-13-2018 09-30-2018 10-Q
27 08-14-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

vaccinex-to-report-new-clinical-results-of-neoadjuvant-treatment-with-pepinemab-to-enhance-immunotherapy-in-patients-with-head-and-neck-cancer-at-asco-annual-meeting
Vaccinex To Report New Clinical Results Of...
05/27/2025 12:47:12

Vaccinex, Inc. (NASDAQ:VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer an...

vaccinex-to-report-promising-new-clinical-data-revealing-pepinemabs-unique-mechanism-to-enhance-immunotherapy-at-aacr-in-chicago
Vaccinex To Report Promising New Clinical ...
04/21/2025 12:47:53

Neoadjuvant treatment with pepinemab appears to induce abundant, mature lymphoid structures that correlate with durable clinica...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
12/17/2024 21:05:45

vaccinex-faces-nasdaq-delisting-whats-going-on-with-the-stock
Vaccinex Faces Nasdaq Delisting: What's Go...
12/17/2024 18:07:50

Vaccinex, Inc. (NASDAQ: VCNX) shares are trading lower after the company announced it received a delisting notification from Na...

crude-oil-down-over-1-us-industrial-production-declines-in-november
Crude Oil Down Over 1%; US Industrial Prod...
12/17/2024 17:37:10

dow-dips-over-200-points-us-retail-sales-top-estimates
Dow Dips Over 200 Points; US Retail Sales ...
12/17/2024 14:46:54

vaccinex-announces-nasdaq-delisting-notification
Vaccinex Announces Nasdaq Delisting Notifi...
12/17/2024 14:01:21

vaccinex-has-been-granted-australian-patent-number-2018237549-titled-treatment-of-cancer-with-a-semaphorin-4d-antibody-in-combination-with-an-epigenetic-modulating-agent
Vaccinex Has Been Granted Australian Paten...
12/02/2024 20:58:54

https://ipsearch.ipaustralia.gov.au/patents/2018237549

vaccinex-q3-eps-283-vs-1525-yoy-revenue-52k-vs-20k-yoy-cash-cash-equivalents-and-marketable-securities-as-of-sept-30-were-29m
Vaccinex Q3 EPS $(2.83) vs $(15.25) YoY, R...
11/18/2024 13:37:04

vaccinex-announces-signing-of-proprietary-project-agreements-with-amgen-merck-chugai-absci-gigagen-merus-soleil-thirdarc-and-incyte-to-employ-vaccinexs-activmab-technology
Vaccinex Announces Signing Of Proprietary ...
11/07/2024 13:33:43

vaccinex-reports-improved-immunity-correlating-with-clinical-benefit-of-pepinemab-combination-treatment-at-society-for-immunotherapy-of-cancers-annual-meeting
Vaccinex Reports Improved Immunity Correla...
11/05/2024 13:32:19

Vaccinex, Inc. (NASDAQ:VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer an...

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
11/01/2024 20:36:26

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
10/31/2024 16:34:06

vaccinex-shares-resume-trade
Vaccinex Shares Resume Trade
10/31/2024 14:22:05

vaccinex-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-620
Vaccinex Shares Halted On Circuit Breaker ...
10/31/2024 14:02:44

vaccinex-reports-new-findings-for-signal-ad-phase-1b2-trial-of-pepinemab-at-clinical-trials-on-alzheimers-disease-conference-in-madrid-spain-reports-that-expression-of-plasma-gfap-and-pp-tau-217-biomarkers-appears-to-increase-predominantly-during-mci-and-that-this-is-inhibited-by-pepinemab-treatment
Vaccinex Reports New Findings For SIGNAL-A...
10/31/2024 14:02:16

Vaccinex (NASDAQ:VCNX) today provided an update on new clinical findings from its SIGNAL-AD Phase 1b/2 trial of pepinemab antib...

vaccinex-to-report-data-for-signal-ad-phase-1b2-trial-of-pepinemab-at-clinical-trials-on-alzheimers-disease-conference
Vaccinex To Report Data For SIGNAL-AD Phas...
10/24/2024 12:37:25

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
10/15/2024 20:30:52

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
10/10/2024 16:31:42

whats-going-on-with-vaccinex-stock-wednesday
What's Going On With Vaccinex Stock Wednes...
09/18/2024 17:33:43

Vaccinex shares are trading lower on Wednesday after the company announced $6.2 million in proceeds from the exercise of warran...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION